
Scott Bratman
@scottbratman
cancer researcher | entrepreneur | physician-scientist @pmcancercentre @UofTDRO & @MBPatUofT | ctDNA | radbio | precision medicine
ID: 841238393363283968
13-03-2017 10:43:57
48 Tweet
723 Followers
206 Following

Proud of our work appearing in Nucleic Acids Res led by former graduate student Nina Wang in collaboration with Pugh Lab as well as John Dick, Sagi Abelson & Liran Shlush – highly relevant to accurate mutation detection for liquid biopsy and other applications. doi.org/10.1093/nar/gk…


We have a growing and dynamic liquid biopsy program Princess Margaret Cancer Centre Looking for motivated computational biologists to join us in Toronto! #liquidbiopsy Pugh Lab Daniel De Carvalho hansenhe recruitingsite.com/csbsites/uhnca…

Great presentation by Justin M. Burgener today at the AACR Liquid Biopsies meeting, showing off his beautiful work in collaboration with Daniel De Carvalho on ctDNA methylomic and mutational analysis. This multi-modal approach is desperately needed in our field.

Meet our #STARS21atUT scholars (6/25): Steven De Michino is a 2nd-year MSc student in Dr. Scott Bratman’s lab Princess Margaret Cancer Centre. His project focuses on the exploration of #epigenetic profiles in circulating tumor DNA to identify predictive #CancerBiomarkers!


Check out our new preprint — the product of a rewarding collaboration with Michael Hoffman and Mathieu Lupien labs Princess Margaret Cancer Centre. Kudos to lead author Mehran Karimzadeh

I am grateful for my team members at CCTG, Princess Margaret Cancer Centre, and Radiation Oncology – as well as funding through CIHR and Research at Canadian Cancer Society – for supporting the CCTG HN.10 trial! Accrual is going well despite current challenges.

Thanks Toni Toni Choueiri, MD ! This was a very rewarding collaboration! Looking forward to move this project forward!


Great work Ariana Rostami!! And many thanks to Vuk Stambolic for the collaboration and support! There are still many unanswered questions about how cell-free DNA kinetics can be leveraged to reveal underlying biology and response to treatments. More to come!

Great to see our work with Daniel De Carvalho on ctDNA in head and neck cancer appear in Clinical Cancer Research! Kudos to Justin M. Burgener for leading this from start to finish. Thanks to STARS21 at UT The Princess Margaret Cancer Foundation ASCO Ontario Institute for Cancer Research (OICR) CIHR for supporting our work. clincancerres.aacrjournals.org/content/early/…

I'm very happy to see this collaborative research on HPV ctDNA detection published on-line today Clinical Cancer Research! clincancerres.aacrjournals.org/content/early/… Also a nice summary posted here: uhn.ca/corporate/News…

Please RT! We have a fully funded post-doc position in our group UC San Francisco: perfect for someone with #proteomics expertise who wants to get into cancer #immunotherapy development. Join us in beautiful San Francisco! wiitalab.ucsf.edu/postdoctoral-p…



It was a pleasure working on this review with star postdocs Eric Stutheit-Zhao and Enrique Sanz-Garcia along with Lillian Siu — I am excited about the implementation of these tools for the benefit of future cancer patients.



📢@ESMO24 concomitant paper: Clinical validation of a tissue-agnostic genome-wide methylome enrichment MRD assay for head and neck malignancies. #ESMO24 #HeadandNeckCancer Adela UHN Research Daniel De Carvalho Scott Bratman tinyurl.com/2bkueo7a


Great to see this! It is a culmination of years of work starting with pioneering research from Daniel De Carvalho supported by The Princess Margaret Cancer Foundation. Also a testament to efforts of the Head & Neck Translational Research Program Princess Margaret Cancer Centre to advance innovative technologies into the clinic
